![]() |
市场调查报告书
商品编码
1797673
组织黏合剂的全球市场:类型·用途·终端用户·各地区 (~2035年)Global Tissue Adhesives Market Research Report by Type, by Application, by End User, and by Region Forecast till 2035 |
预计2035年,全球组织黏合剂市场规模将达到68.9亿美元,预测期内的复合年增长率为9.06%。
组织黏合剂是一种专用医用黏合剂,主要用于皮肤伤口闭合。透过与组织牢固黏合,组织黏合剂提供了一种创伤性较小的伤口闭合方法,从而加快伤口癒合速度并改善美观效果。
仿生黏合剂、奈米技术增强黏合剂和聚合物基黏合剂的创新正在彻底改变伤口闭合。这些进步提高了黏合强度,缩短了闭合时间,并降低了感染风险,使组织黏合剂成为现代微创手术的重要组成部分。此外,凝胶和喷雾等改进的给药系统正在加速普及,使下一代黏合剂成为全球高效、永续、以患者为中心的外科护理的基础。
区域洞察
北美仍是最大的区域市场,占全球收入的40%以上。心血管、骨科和重建手术病例的大量增加使得组织黏合剂成为现代外科手术的重要组成部分。预计到2024年,美国将以9.1372亿美元的市场规模占北美市场的主导地位,其次是加拿大,市场规模达1.999亿美元。美国仍然是欧洲大陆最强大的市场,这主要归功于其庞大的研发投入和对新型生物基黏合剂的快速应用。
在欧洲,组织黏合剂在专科外科手术中的应用正在稳步扩大。德国、英国和法国是主要的收入来源。预计到2024年,德国将成为欧洲最大的市场,市场规模达2.0281亿美元,其次是英国,市场规模达1.529亿美元,法国则达1.276亿美元。欧洲医疗保健系统着重缩短住院时间和恢復时间,而组织黏合剂的优势与这一趋势相得益彰。
亚太市场快速成长的动力源于其所需的大量外科手术以及人们对非侵入性伤口闭合方法日益增长的认识。到2024年,中国将以1.3408亿美元的市场规模领先亚太市场,其次是日本(1.1207亿美元)和印度(9,885万美元)。受医疗保健覆盖范围不断扩大和外科手术数量不断增加的推动,这些国家将主导亚太地区的需求。尤其是中国和印度市场,由于创伤病例激增、私立和公立医院投资增加以及政府主导的促进外科耗材国产化的举措,正在经历快速增长。
本报告研究了全球组织黏合剂市场,提供了市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。
Global Tissue Adhesives Market Research Report by Type [Synthetic & semi-Synthetic Adhesives (Cyanoacrylates, Polyethylene Glycol, Gelatin-Formaldehyde, Others), Natural Adhesives (Fibrin, Collagen, Dextran, Chitosan, Others)], by Application [Surgery (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Plastic & Reconstructive Surgery, Ophthalmic Surgery, Urological Surgery, Thoracic Surgery, Others), Wound Care, Burn Treatment], by End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Research Laboratories & Institutes), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
The global tissue adhesives market is expected to reach USD 6.89 billion by 2035 at a CAGR of 9.06%. Tissue adhesives are medically specialized glues that are essentially beneficial for closing wounds in the skin. Moreover, by bonding to the tissue tightly and securely, they offer a less intrusion method of wound closure, thus generally leading to faster healing and better aesthetic results.
Innovation in bio-inspired, nanotechnology-enhanced, and polymer-based adhesives is transforming wound closure. These advancements improve bonding strength, cut closure times, and reduce infection risk, making tissue adhesives vital in modern minimally invasive surgeries. Enhanced delivery systems such as gels and sprays further accelerate adoption, positioning next-generation adhesives as a cornerstone of patient-centric, efficient, and sustainable surgical care worldwide.
Major Company Developments
B. Braun continues to strengthen its global footprint by emphasizing innovation, advanced technologies, and patient-centric healthcare solutions. The company invests heavily in R&D to develop next-generation products and improve existing ones, ensuring responsiveness to unmet medical needs. Its strategy revolves around four pillars-collaboration, cutting-edge integration, digital excellence, and customer alignment. In Hospital Care, the company is optimizing infusion pumps with integrated medication management systems. Aesculap focuses on expanding digital and robotic-assisted surgical solutions, while Avitum advances efficiency and connectivity in dialysis therapies. With ongoing refinement of chronic and acute treatment offerings, B. Braun is well-positioned to provide seamless, technology-driven solutions that enhance clinical efficiency, patient safety, and healthcare outcomes worldwide.
Major players in the global tissue adhesives market are Meyer Haake GmbH, Essity, Zhejiang Perfectseal, Baxter, Chemence Medical, Inc., H.B. Fuller Medical Adhesive Technologies, LLC., Becton, Dickson and Company (BD), B. Braun, Artivion, GEM SRL, Advanced Medical Solutions (AMS), and Cohera Medical, Inc.
Report Attribute Details
Market Size 2024 USD 2,649.88 Million
Market Size 2035 USD 6,892.51 Million
CAGR (2025-2035) 9.06%
Base Year 2024
Market Forecast Period 2025-2035
Historical Data 2019, 2022, 2023
By Type: Synthetic & Semi-Synthetic Adhesives - 8.30%, Natural Adhesives - 10.20%.
By Application: Surgery- 9.04%, Wound Care - 10.42%.
By End User: Hospitals and Specialty Clinics - 8.62%, Ambulatory Surgical Centers (ASCs) - 10.13%.
Regional Insights
North America is still the largest regional market by far, making up more than 40% of the total revenue share worldwide. The numerous cases of cardio-vascular, orthopedic, and reconstructive surgery have made tissue adhesives a must-have in modern surgical procedures. The U.S. dominates the North American tissue adhesives market with USD 913.72 million in 2024, while Canada follows with USD 199.90 million. The U.S. is still the most powerful country on the continent, primarily due to the large R&D investments and quick adoption of novel bio-based adhesives.
Europe demonstrates robust usage of tissue adhesives in specialized surgeries, where Germany, the UK, and France have been the major revenue centers. Germany is Europe's largest tissue adhesives market at USD 202.81 million in 2024, followed by the UK with USD 152.90 million and France with USD 127.60 million. The healthcare systems in Europe are focusing on shortened hospital stays and quicker recovery times, which is compatible with the effectiveness provided by tissue adhesives.
The drive behind the fast growth of the Asia-Pacific market is the huge volume of surgical procedures required and the increasing recognition of non-invasive wound closure methods. China tops the APAC tissue adhesives market with USD 134.08 million in 2024, followed by Japan at USD 112.07 million and India at USD 98.85 million. These countries dominate regional demand, fueled by expanding healthcare access and surgical procedures. China and India's markets are expanding rapidly due to a surge in trauma cases and rising investments in both private and public hospitals, supported by the government-backed initiatives to localize production of surgical consumables.
The Rest of the World market is growing steadily, led by Brazil's rise in cosmetic surgeries, Gulf states' investments in advanced healthcare, and gradual adoption in Africa, supported by global healthcare partnerships despite access and cost challenges.